 | BioAtla, Inc. | |||
| NGM : BCAB || Location: United States | ||||
$2.18+0.08 (+3.56%) |
0.87 M | 2.01 - 2.18 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 5.588 M |
| March 15, 2024 | 5.127 M |
| Feb. 29, 2024 | 5.106 M |
| Feb. 15, 2024 | 5.039 M |
| Jan. 31, 2024 | 4.728 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.82 | -0.70 | 14.22% |
| 06/30/2023 | -0.65 | -0.75 | -14.89% |
| 03/31/2023 | -0.64 | -0.58 | 9.46% |
| 12/31/2022 | -0.71 | -0.63 | 11.44% |
| 09/30/2022 | -0.80 | -0.69 | 13.80% |
BCAB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 48.097M | Shares Float | 33.839M |
| Short Float | 5.588M | Market Cap | 104.85M |
| Institution ownership | 64.48% | Insider ownership | 9.681% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.58 | Forward EPS | -1.93 |